| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |